Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic characterization of a virulent multidrug-resistant Salmonella enterica serovar Enteritidis strain isolated from meat rabbits (Oryctolagus cuniculus) in China.

BMC microbiology·2026
Same author

Macrophage-cancer cell crosstalk in breast cancer chemotherapy resistance.

Medical oncology (Northwood, London, England)·2025
Same author

Electroacupuncture-Medication Combined Therapy Improves Sepsis Outcomes by Regulating PVN Neuronal Activities.

Current medical science·2025
Same author

High‑fat diet and cognitive dysfunction: Mechanistic insights into diet‑induced neurodegeneration (Review).

International journal of molecular medicine·2025
Same author

Molecular mechanisms and potential targeting strategies of ubiquitin‑proteasome system‑mediated PD‑1/PD‑L1 ubiquitination in tumor immune suppression (Review).

Oncology reports·2025
Same author

Exploring the Allosteric Pathways of Asciminib in the Dual Inhibition of BCR-ABL1.

Biomolecules·2025

Related Experiment Video

Updated: Apr 21, 2026

PCR Mutagenesis, Cloning, Expression, Fast Protein Purification Protocols and Crystallization of the Wild Type and Mutant Forms of Tryptophan Synthase
09:31

PCR Mutagenesis, Cloning, Expression, Fast Protein Purification Protocols and Crystallization of the Wild Type and Mutant Forms of Tryptophan Synthase

Published on: September 26, 2020

3.7K

Heparin makes differences: a molecular dynamics simulation study on the human βII-tryptase monomer.

Yan Wang1, Qing-Chuan Zheng, Chui-Peng Kong

  • 1State Key Laboratory of Theoretical and Computational Chemistry, Institute of Theoretical Chemistry, Jilin University, Changchun 130023, P. R. China. zhengqc@jlu.edu.cn zhanghx@mail.jlu.edu.cn.

Molecular Biosystems
|November 5, 2014
PubMed
Summary

Heparin stabilizes human beta-tryptase structure through salt bridge interactions, revealing key residues for inhibitor design in inflammatory and allergy diseases.

More Related Videos

X-Ray Crystallography to Study the Oligomeric State Transition of the Thermotoga maritima M42 Aminopeptidase TmPep1050
11:27

X-Ray Crystallography to Study the Oligomeric State Transition of the Thermotoga maritima M42 Aminopeptidase TmPep1050

Published on: May 13, 2020

3.4K
Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
05:56

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches

Published on: October 13, 2022

1.5K

Related Experiment Videos

Last Updated: Apr 21, 2026

PCR Mutagenesis, Cloning, Expression, Fast Protein Purification Protocols and Crystallization of the Wild Type and Mutant Forms of Tryptophan Synthase
09:31

PCR Mutagenesis, Cloning, Expression, Fast Protein Purification Protocols and Crystallization of the Wild Type and Mutant Forms of Tryptophan Synthase

Published on: September 26, 2020

3.7K
X-Ray Crystallography to Study the Oligomeric State Transition of the Thermotoga maritima M42 Aminopeptidase TmPep1050
11:27

X-Ray Crystallography to Study the Oligomeric State Transition of the Thermotoga maritima M42 Aminopeptidase TmPep1050

Published on: May 13, 2020

3.4K
Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
05:56

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches

Published on: October 13, 2022

1.5K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Human beta-tryptase (hBTM) is a mast cell enzyme crucial for inflammatory and allergy diseases.
  • Heparin is known to stabilize tryptase structure and maintain its activity.
  • The precise interaction between heparin and hBTM at atomic resolution remains uncharacterized.

Purpose of the Study:

  • To elucidate the structure-function relationship between heparin and the human beta-tryptase monomer.
  • To investigate the molecular mechanisms of heparin binding to hBTM.
  • To identify key residues involved in heparin-hBTM interactions for potential therapeutic targeting.

Main Methods:

  • Molecular docking simulations to predict binding modes.
  • Molecular dynamics (MD) simulations to analyze structural stability and interactions.
  • MM-GB/SA calculations to assess binding free energy.
  • Averaged noncovalent interaction (aNCI) method for interaction visualization.

Main Results:

  • Heparin binding significantly stabilizes the hBTM structure primarily via salt bridge interactions.
  • A critical loop containing Arg188 and Asp189 was identified as a salt bridge intermediary.
  • These residues mediate the interaction between heparin and the P1 group of the ligand (0GX), influencing its orientation.

Conclusions:

  • Heparin's stabilizing effect on hBTM is mediated by specific salt bridge interactions involving key residues.
  • Understanding these binding characteristics provides insights into hBTM regulation.
  • This knowledge can guide the rational design of novel inhibitors for treating inflammatory and allergic conditions.